Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Nodzon

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Treatment Options in Oncology|September 17, 2024
The Role of Nursing in the Delivery of Cardio-OncologyAnecita Fadol, Lisa Nodzon, Geraldine Lee
Journal of the Advanced Practitioner in Oncology|April 4, 2022
Cardiovascular Adverse Events and Mitigation Strategies for Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor TherapyLisa Nodzon, Anecita Fadol, Sara Tinsley
Oncology Nursing Forum|May 8, 2023
An Integrative Review of Sex Differences in Quality of Life and Symptoms Among Survivors of Hematologic MalignanciesSara M Tinsley-Vance, Dorothie S Durosier Mertilus, Lisa Nodzon, et al.
Leukemia Research Reports|September 6, 2019
T315I-mutated myeloid sarcomaYumeng Zhang, David M Swoboda, Aditya Grover, et al.
Asia-Pacific Journal of Oncology Nursing|April 8, 2026
Developing a cardio-oncology education programme for nursesGerry Lee, Lisa Nodzon, Chelsea P Kriesberg, et al.
Blood Advances|February 12, 2020
Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemiaOnyee Chan, Chetasi Talati, Leidy Isenalumhe, et al.
Cardio-Oncology (London, England)|January 17, 2025
Nursing knowledge in cardio-oncology: results of an international learning needs-assessment surveyAnecita Fadol, Geraldine Lee, Valerie Shelton, et al.
Cardio-Oncology (London, England)|May 27, 2026
Cardio-Oncology Nursing Education (CONE): an innovative educational program for nurses caring for patients with cancer and concurrent cardiovascular diseaseAnecita Fadol, Lisa Nodzon, Priya Reehal, et al.
Leukemia Research|October 20, 2018
A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of diseaseKendra Sweet, Lori Hazlehurst, Eva Sahakian, et al.
Therapeutic Advances in Hematology|December 30, 2025
Ibrutinib oral suspension bioavailability and compatibility for optimal enteral administration routeJonas Paludo, Lisa Nodzon, Xavier Woot de Trixhe, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Treatment Options in Oncology|September 17, 2024
The Role of Nursing in the Delivery of Cardio-OncologyAnecita Fadol, Lisa Nodzon, Geraldine Lee
Journal of the Advanced Practitioner in Oncology|April 4, 2022
Cardiovascular Adverse Events and Mitigation Strategies for Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor TherapyLisa Nodzon, Anecita Fadol, Sara Tinsley
Oncology Nursing Forum|May 8, 2023
An Integrative Review of Sex Differences in Quality of Life and Symptoms Among Survivors of Hematologic MalignanciesSara M Tinsley-Vance, Dorothie S Durosier Mertilus, Lisa Nodzon, et al.
Leukemia Research Reports|September 6, 2019
T315I-mutated myeloid sarcomaYumeng Zhang, David M Swoboda, Aditya Grover, et al.
Asia-Pacific Journal of Oncology Nursing|April 8, 2026
Developing a cardio-oncology education programme for nursesGerry Lee, Lisa Nodzon, Chelsea P Kriesberg, et al.
Blood Advances|February 12, 2020
Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemiaOnyee Chan, Chetasi Talati, Leidy Isenalumhe, et al.
Cardio-Oncology (London, England)|January 17, 2025
Nursing knowledge in cardio-oncology: results of an international learning needs-assessment surveyAnecita Fadol, Geraldine Lee, Valerie Shelton, et al.
Cardio-Oncology (London, England)|May 27, 2026
Cardio-Oncology Nursing Education (CONE): an innovative educational program for nurses caring for patients with cancer and concurrent cardiovascular diseaseAnecita Fadol, Lisa Nodzon, Priya Reehal, et al.
Leukemia Research|October 20, 2018
A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of diseaseKendra Sweet, Lori Hazlehurst, Eva Sahakian, et al.
Therapeutic Advances in Hematology|December 30, 2025
Ibrutinib oral suspension bioavailability and compatibility for optimal enteral administration routeJonas Paludo, Lisa Nodzon, Xavier Woot de Trixhe, et al.
Pageof 2